Mylan (NSDQ:MYL) said today that it launched its buprenorphine and naloxone sublingual film as a generic of Indivior‘s (LON:INDV) Suboxone sublingual film.
The product is indicated for the treatment of opioid dependence. The therapy should be used alongside counseling and psychosocial support for people living with opioid dependence, according to Mylan.
Get the full story at our sister site, Drug Delivery Business News.
The post Mylan launches generic sublingual film for opioid dependence appeared first on MassDevice.
from MassDevice https://ift.tt/2U3wytN
Cap comentari:
Publica un comentari a l'entrada